IV things (exam 2) Flashcards

1
Q

What is the definition of parenteral?

A

adj: administered by any way other than through the mouth: applied, for ex, to the introduction of drugs or other agents into the body by injection
para enteron: beside from the intestine

parenteral products must be sterile!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Definition of aseptic technique

A

-the ability of personnel to manipulate sterile preparations, sterile packaging components, & sterile administration devices in a way that excludes the introduction of viable microorganisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Intravenous injections

A
  • peripheral: injection to the arm or leg

* central: use of a central venous catheter)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Intra-arterial (IA)

A
  • uncommon for the administration of medication –> to the high pressure side of the circulatory system
  • testing (1st pass kinetics, arterial pressure)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Intramuscular (IM)

A

-injection to within muscle tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Intrathecal (IT)

A

-injection to the meninges of the spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Epidural

A

-injection to the tissues surrounding the spinal cord, not the spinal cord itself

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

intradermal (ID)

A

injection within the skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Subcutaneous (Sc, SQ)

A

injection beneath the skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Definition of Sterility

A
  • freedom from all living organisms, an absolute term & no such thing as almost sterile*
  • all parenteral & ophthalmic dosage forms must be sterile!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Health status in terms of sterility

A
  • sterile prep personnel should be free from infectious diseases
  • -> if you have a “cold” and are coughing and/or sneezing stay out of the sterile prep room!

(chills, fever)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Personal Prep for sterile room

A
  • cover both head and facial hair
  • remove cosmetics likely to flake

-remove finger and wrist jewelry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hand-washing rules

A
  • scrub hands & arms to elbows
  • plain soap and water not enough for high risk situations (alcohol, chlorhexidine gluconate, iodophors, hexachliphene, parachlorometaxylenol & triclosan)
  • use 3-5ml for 30 secs
  • wash hands even if gloves are to be worn (leakage rate can be more than 50%) also wash hands after gloves removed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Gloves

A
  • selection based on type of compounding, material durability, reliability, comfort & protection from bacteria or hazardous drug penetration
  • for IV room- use SURGICAL gloves

-change ~1 hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Glove composition**

A
  • latex
  • vinyl

-synthetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Gowns

A
  • should be made of a low-particulate material that protects against bacterial passage and drug permeability
  • Tyvek: standard for non-permeable garments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

other coverings (shoes & masks)

A
  • shoe covers & sticky mats (change frequently)
  • masks: don just prior to working in hood, change each time leaving compounding area, surgical masks offer no protection against inhaling of powdered or aerosolized hazardous drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

LAFS horizontal flow hood

A
  • filtered air is directed toward the pharmacist/tech from a plenum (and HEPA filter) located at the back of the hood
  • most common for general purpose parenteral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

BSC Vertical flow hood

A
  • filtered air is directed downward from a plenum (and HEPA filter) located at the top of the hood
  • used for chemo therapy

-provides more protection for the pharmacist/tech than does the horizontal hood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Laminar Air Flow

A
  • HEPA Filter removes 99.97% of all particles 0.3 microns or larger
  • operate for at least 15 min prior to use –> most institutions require 30 mins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the greatest disadvantage of a laminar air flow vibe?

A

a false sense of security

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

ISO classifications of particulate matter in room air

A

(0.5 um and >) theres a whole chart but basically the smaller the number- the higher the air quality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are pyrogens?

A
  • metabolic products of living organisms, or the dead microorganisms themselves
  • chemically: lipopolysassharides, soluble in water but insoluble in organic solvents

-aseptic technique (ideally) prevents the introduction of pyrogens to parenteral products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

pharmacologic effects of pyrogens

A
  • vary with the microbial source of the pyrogen & pt receiving the injection
  • in man, pyrogenic reaction is fever & chills
  • following injection, latent period 45-90 mins, then rapid rise in body temp, chills, headache & malaise
  • anaphylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Sources of pyrogens

A
  • water used as the solvent
  • containers used in preparation, packaging, storage or administration

-chemicals used in the preparation of the solution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Elimination of pyrogens

A
  • dry heat: for metal and glass containers
  • chemically: for solutions (disadvantage: can destroy drugs)

-synthetic filter media: 0.22 micron filter
Best approach: prevent them from occurring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

unnecessary factors for when preparing sterile products

A

talking, laughing, chewing gum, eat/drink

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

CSP risk levels

A

-assigned according to relative possibility that a compounded sterile product might become contaminated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

*LAFS

A

laminar airflow system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

*BSC

A

biologic safety cabinet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

RABS (CAI & CACI)

A

-restricted access barrier system
CAI: compounding aseptic isolator

CACI: compounding aseptic containment isolator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Clean rooms: an environment where contamination is limited/controlled to prevent:

A

particles, organisms & pyrogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Clean rooms: environmental control:

A

temperature, humidity & relative barometric pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Clean room design (list all the things in there and they supplies they are made from)

A
  • layout: equipment & traffic flow
  • walls: epoxy coated
  • flooring: seamless, vinyl
  • ceiling system: gasketed, t-grid
  • filtreation/Air flow: HEPA, positive pressure
  • lighting: sealed, gasketed
  • easy clean surfaces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Clean room classifications: class 100,000

A
  • particle count not to exceed a total of 100,000 particles per cubic foot of a size 0.5 micron and larger
  • and/or 700 particles per cubic foot of a size 5 microns and larger
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Clean room classifications: class 100

A
  • particle count not to exceed a total of 100 particles per cubic foot of a size 0.5 micron and larger
  • and/or 0.7 particles per cubic foot of a size 5 micron and larger
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

end product testing: product observation

A
  • container leaks & integrity
  • particulates in solution

-solution color, volume and odor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

end product testing: retrospective check:

A
  • calculations
  • ingredients
  • quantities
  • containers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

end product testing: analytical testing

A
  • evaluates the contents of prepared sterile products

- weight verification (specific gravity), refractometry verification, spectrometry, pH testing, microbial testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Process Validation

A
  • systematically demonstrates that a process will reproducibly meet its claim
  • involves manipulation of microbial growth media according to the aseptic process being validated

-should schedule process under worst conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

How to validate aseptic processes

A
  • a growth medium: is introduced with a sample of the process being evaluated (product/process sample)
  • the medium will support organisms introduced to the process by the operator
  • the sample must be a product of the same aseptic process being validated
  • should be conducted: at random intervals & without the operator’s knowledge*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

more stability: 3 things in green

A
  • the extent to which a Rx preparation remains within specified limits in terms of: chemical composition, physical composition & microbiologic activity/contamination
  • at the time of use a medication must be: at the stated potency & safe for administration to the pt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Product stability:

A

is subject to specific storage conditions & is the primary basis for an expiration date/time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Lyophilization

A
  • drugs in solution tend to be less stable than those in dry or suspended form
  • a process of rapid freezing & drying under high vacuum (sublimation), the product is a dry powder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Sterilization

A
  • 0.22 micron filter

- autoclave

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

antioxidants

A
  • metasulfite & sulfite ions

- sodium salts, potassium salts (metabisulfite, bisulfite & sulfite)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Inert and semi-inert gasses

A

nitrogen, carbon dioxide & helium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Particulate matter

A

-may be present in parenteral products: undesirable, unintentional, potentially harmful to the pt, mobile, undissolved substances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Sources of particulate matter

A
  • IV solution and/or additives: manufacturing process
  • packaging components: paper, cardboard
  • IV tubing/sets and administration devices
  • preparation processes: laminar flow hood, patient bedside
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

IV fluid incompatibility*

A
  • occurs when a drug is combined with an IV fluid or another drug, to produce by physiochemical means, a product unsuitable for administration to the patient *
    ex: phenytoin in D5W (a physical & chemical incompatibility)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Therapeutic classification of incompatibilities

A

-2 or more drugs administered concurrently, result in undesirable antagonistic or synergistic pharmacologic action - drug/drug interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Physical classification of incompatibilities

A

the combination of ONE or more drugs in solution resulting in compositional change & appearance (change in color, formation of turbidity, precipitation & evolution of a gas)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Chemical classification of incompatibilites

A

-degradation of drug substances as a result of being in solution & as a result of being in contact with other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

The greatest single factors (3) causing incompatibility between IV fluids and their contents:

A

variations in pH, solubility & stability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

minimizing incompatibilities

A
  • use freshly prepared solutions whenever possible
  • encourage use of as few additions as possible
  • study to demonstrate proficiency in IV therapy
  • educate MDs/Rns
  • be skillfull with reference materials (Trissel’s, Clinical Pharmacology)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Parenteral administration advantages

A
  • fast
  • some drugs not effective orally
  • uncomplicated admin. where the pt is: uncooperative, nauseous, unconscious NPO
  • patient compliance: gives MD control of drug, pt must return for therapy, cant trust some pts to take medications
  • correction of fluid/electrolyte imbalance
  • TPN administration: when pt is NPO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Parenteral administration disadvantages

A
  • special training required (special procedure, aseptic)
  • invasive
  • pain
  • difficult to reverse
  • more expensive
  • incompatibilities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

IV compatibility idk other green things to know

A
  • -in general, use smallest possible bag
  • refrigerate vs room temp
  • light sensitivity
  • pay attention to manufacture’s codes when provided*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

sterility & integrity requirements for sterile IV admixtures

A

freedom from living organisms, freedom from dead organisms & pyrogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

H2O insoluble

A

dead organisms, parts of dead organisms & metabolic products of organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

H2O soluble

A

lipopolysaccharides, metabolic products of organisms

62
Q

hypotonic

A

< 277 mM

63
Q

isotonic

A

~277 mM

64
Q

hypertonic

A

> 277 mM

65
Q

where does the central route access?

A
  • major veins
  • access to the venous system close to the heart

-superior vena cava, inferior vena cava & subclavian vein (PICC line)

66
Q

indications for peripheral admin.

A
  • administration of drugs
  • administration of fluids (maintain hydration & volume)
  • surgery (anesthesia, drugs)
  • transfusion
  • to maintain or correct electrolyte imbalance
  • administration of nutritional solutions
67
Q

advantages of peripheral admin (with respect to central**

A
  • veins are relatively easy to access
  • drugs, solutions and blood can be administered quickly

-administration is easy to see and monitor

68
Q

Disadvantages of peripheral admin (with respect to central) **

A
  • short term access
  • immobilization of the limb

-less forgiving of tonicity extremes

69
Q

indications for central admin

A
  • large volume fluids
  • hypo/hypertonic fluids

-pH imbalanced fluids

70
Q

**advantages of central admin (compared to peripheral)

A

1-rapid infusion of large volumes
2-a means of measuring CVP (*central venous pressure)

3-eliminates repeat peripheral venipuncture (decreased vein irritation & vein damage)
4-decrease patient discomfort

71
Q

**disadvantages of central admin. (with respect to peripheral)

A

risk of complications: pneumothorax, sepsis, thrombosis/embolism, organ perforation
-decreased in patient mobility

-surgical implant

72
Q

intra-aeticular

A

*injection to the joints

73
Q

intra-synovial

A

*injection to the joint fluid areas

74
Q

intraventicular

A

*injection to the ventricles of the brain

75
Q

intra-cardiac

A

*injection to the heart (epi)

76
Q

Potential complications of IV therapy

A
  • bad news: most medical & pharmacologic interventions present some risk to patient
  • parenteral therapies are more likely to have serious complications
  • good news: most complications can be prevented or minimized
  • precautions
77
Q

phlebitis

A
  • inflammation of the veins
  • can be induced by insertion of VADs vascular access device
  • characterized by tenderness, redness, puffiness, hardness & increased temp
  • at tip of VAD & in the direction of blood flow
78
Q

extravasation

A
  • undesirable
  • liquids are infused into peripheral space surrounding vein

-misplaced VAD

79
Q

infiltration

A
  • undesirable

- extravasation fluids are absorbed by surrounding tissues

80
Q

Extravasation/Infiltration (general signs and symptoms)

A

-at the IV site: pain, discomfort, burning, feeling of tightness, decreased temp, cant back flow blood, decreased flow rate

81
Q

Extravasation/Infiltration (drug specific signs & symptoms)

A
  • tonicity & pH extremes (hypo/hypertonic solutions)–> v irritating
  • tissue necrosis: chemo, dopamine, epinephrine
82
Q

infection

A

local: contaminated IV site and/or tissues near VAD, sterile and non-sterile necrosis & sepsis (tissue destruction)
Systemic: fever, chills, malaise & septicemia

83
Q

Air Embolism

A
  • an object blocking a blood vessel- blood clot, fat, amniotic fluid, air, other objects –> MI
  • > 5ml of air- right ventricle of the heart, cavitation & fatal
84
Q

Air embolism (signs and symptoms)

A

-respiratory distress, weak pulse, increased CVP, decreased BP & unconsciousness

85
Q

Allergic reactions

A

-histamine release: itching, tearing, runny nose, coughing, wheezing, anaphylaxis

86
Q

Injection def:

A

-a drug in solution or lyophilized powder in a suitable vehicle intended for parenteral administration

87
Q

Infusion fluid

A
  • IVF, intermittent, single, small volume dose (50 ml, 100 ml) *
  • continuous infusion, single large volume dose (ex: D5W- 1000 mL)
88
Q

Sterile solids labeled: sterile drug

A

-no buffers, no diluents, no added substances

89
Q

Sterile solids labeled: drug for injection

A

-buffers, diluents, added substances

90
Q

Sterile suspension

A
  • drug is initially in dry (lyophilized) form
  • will yield a suspension after reconstitution with a suitable vehicle
    ex: Unasyn (amp/sulb)
91
Q

solutions of irrigation:

A
  • used to bathe or flush open wounds and body cavities (dressings, surgical procedures)
  • never use parenterally
92
Q

what are vehicles (when used for injections):

A
  • water
  • sterile water
  • bacteriostatic water
  • oils (sesame oil)
93
Q

what are some solubilizing agents? (4)

A

polyethylene glycol, propylene glycol, glycerin & ethyl alcohol

94
Q

what is an admixture?

A

-the combination of 2 or more parenteral dosage forms for administration as a single entity
Additives: when a small volume drug is added to a larger volume vehicle, the drug may be referred to as an additive
-large volume solutions: often used to administer electrolytes, often administered alone

95
Q

what is an advantage of an ampule?

A

do not require preservatives

96
Q

what is a disadvantage of ampules?

A

contamination by glass shards upon opening, filtration required

97
Q

what are some advantages of vials?

A

dosing flexibility, decreased waste-multi-dose vial

98
Q

what are some disadvantages of vials?

A
  • coring (going thru that latex rubber stopper)
  • drug interaction with latex
  • latex allergy
  • increased waste- single dose vial*
99
Q

what is dead space?

A

-space collectively occupied by: needle bore, needle hub, luer couplings and all fluid occupying space in a syringe when the plunger is set to zero ml

100
Q

what is vascular pressure?

A
  • pressure within a blood vessel
  • a function of: myocardial contraction, smooth muscle activity in vasculature, hydrostatic force (due to gravity)*
  • applies to venous and arterial vessels
101
Q

infusion pressure

A
  • gravity: drip chamber must be at sufficient height above the infusion site
  • hydrostatic pressure: ex* IA infusion: 140 mm x 13.534 = 1894.76 mm ~ 75”
102
Q

what is resistance?

A

a function of:

  • diameter and length of IV tubing
  • -> resistance to flow increases as tubing diameter decreases, as tubing length increases
  • -> resistance to flow decreases as tubing diameter increases and as tubing length decreases
103
Q

when are infusion pumps indicated?

A
  • a greater degree of infusion accuracy is required (PCA, complicated regimens)
  • higher pressures are required (intra arterial infusion, when multiple resistance factors are present)
  • risk of fluid over load or drug overdose
104
Q

small volume parenteral (SVP)

A

< 150ml*

-piggy back bags, prefilled syringes

105
Q

large volume parenteral (LVP)

A

> 150ml*

-hydration fluids (electrolytes) & TPN

106
Q

glass IV container types

A
  • based upon resistance to water attack, release of alkali

- availability: 1 ml to 3,000 ml

107
Q

advantages of glass containers

A
  • -protection against gas and vapor permeation
  • protection against punctures
  • easy to inspect contents
108
Q

disadvantages of glass containers

A
  • -pH changes due to ion leaching
  • flaking due to: phosphates, citrates, tartrates
  • breakable
  • storage and disposal complications
  • difficult to detect hairline fractures
109
Q

polyvinyl chloride (PVC)

A
  • contains plasticizers (softens container, pliability & may leach into preparation)
  • drug sorption (surface adherence & integration with plastic)
  • incineration
110
Q

Polyolefin

A
  • contains no plasticizers (rigidity or semi-rigidity)
  • no drug soption problems
  • incineration
  • impermeability to air
  • a mixture of polyethylene and polypropylene
111
Q

advantages of plastic containers

A

*disposable, lightweight, inexpensive, unbreakable, minimal storage space, can be frozen & no venting is required (airborne contamination less likely)

112
Q

disadvantages of plastic containers

A

*ports awkward to manipulate (increases touch contamination), absorption/adsoprtion/leaching concerns (PVC), permeability (PVC), difficult to determine fluid levels, difficult to detect particulates, puncture easily (PVC)

113
Q

primary IV set

A
  • usually for a single (primary) fluid
  • for continuous infusion (can be used for intermittent infusions too)
  • exceptions: TPN
114
Q

secondary IV set

A

(never used alone, always with primary)

  • attaches to a primary set at a Y site
  • for continuous or intermittent infusion
115
Q

4 filters and their green def

A

5 micorn: filters most non-living particles

  1. 2 micron: filters most non-living particles, candida
  2. 45 micron: filters gross particulates, filters most fungi and bacteria
  3. 22 micron: filters all bacteria except rickettsia, does not filter pyrogens or viruses
116
Q

Parenteral Nutrition

A
  • the provision of all basic metabolic and nutritional requirements via the IV route
  • central administration (most common & preferred over peripheral)
117
Q

Benefits of parenteral nurition

A
  • all nutrients mixed in single daily container: dextrose, amino acids, fat, electrolytes, trace elements, insulin, drugs
  • one IV pump
  • one administration set
  • touch/manipulation contamination is minimized due to single bag
118
Q

disadvantages of parenteral nutrition

A
  • not all nutrient admixtures are physically and chemically stable
  • some potential combinations *will precipitate and or will crack (fat emulsion)
119
Q

Peripheral parenteral nutrition

A
  • less preferred than central TPN
  • relatively uncommon
  • peripheral route provides low-risk nutritional support for supplement until enteral nutrition established
  • gut may work, but not sufficiently to meet all the patients nutritional needs
120
Q

Harris-Benedict equations

A

Men: BEE = 66.67 + (13.75 * kg) + (5 * ht) - (6.76 * age)
Women: 655.1 + (9.56 * kg) + (1.85 *ht) - (4.68 * age)

121
Q

Caloric TPN Sources

A
  • amino acids (protein): 4 kcal/gram
  • dextrose (glucose): 3.4 kcal/gram
  • fat (lipids): 9 kcal/gram
122
Q

Quick estimate/ short cuts for BEE, maintenance & anabolism

A

BEE = 25 * wt in kg
Maintenance: 30 * wt in kg
anabolism: 35 * wt in kg

123
Q

what to use when administering drugs/fluids to the venous system use:

A
  • needles/syringes, catheters, implanted ports

- establish a connection

124
Q

General considerations for vascular access devices:

A

*vein location, condition and availability, specific indication, infusion rate, tonicity, pH and vesicant potential, duration of therapy, patient compliance/cooperation

125
Q

Venipuncture

A
  • access to arm or hand (leg or foot)
  • metacarpal, cephalic, basilic*
  • safest form of vascular access
  • lowest risk of life threatening complications
  • for short term therapy
126
Q

venipuncture device selection criteria:

A

-catheter length, lumen diameter, infusion rate, osmolarity/ pH of infusion fluids, length of therapy, pt activity level, pts age & body image/scarring

127
Q

Central Venous access

A
  • an indirect connection to: superior vena cava, inferior vena cava
  • most commonly through the subclavian vein: *over the needle, through the needle & over a guidewire (most common)
128
Q

what are used for short term catheres?

A
  • polyurethane, PVC (can pushed into the lumen of the vein into which it is being placed)
129
Q

what is used for long terms catheres?

A

silicone rubber - more flexible so it cannot bt manipulated into some way

130
Q

disadvantages of short-term catheters

A

*tissue irritation, local infection, systemic infection, thrombus formation (PVC), vessel rupture

131
Q

long term catheters (advantage & disadvantage)

A
  • made of silicone rubber: much less thrombogenic than polyurethane or PVC
  • more flexible than short term
  • advantage: physiologically more compatible
  • disadvantage: insertion more difficult than short term catheters
132
Q

Hickman catheter

A
  • silicone rubber
  • single or multiple lumen
  • open ended, tears/kinks easily (disadvantage)
  • requires routine Heparin flush (disadvantage)
  • indicated for ling-term CV access & home therapy
133
Q

Broviac catheter

A
  • single lumen

- small inner lumen: pediatric, elderly, slower infusion rates

134
Q

Groshong catheter

A
  • silicone rubber
  • closed end –> pressure sensitive 2 way valve
  • tears or kinks easily
  • indications: long-term CV access, use for heparin allergy*
135
Q

PICC

A
  • peripherally inserted central venous catheter*
  • silicone rubber
  • beside insertion (advantage)
  • may occlude peripheral vessels, long path to CV circulation (disadvantage)
  • indications: long-terms CV access, head and/or neck injury
136
Q

Cytotoxic drugs

A

-a drug that damage or destroys cells and is used to treat various types of cancer
AKA: chemotherapeutic drugs, antineoplastic drugs, antimetabolic drugs,

137
Q

MOA of cytotoxic drugs

A

-inhibition of cell growth and/or division of cancer cells

Selective towards: * cancers, tumors, bone marrow, skin, epithelial tissues, fetal tissue, hair follicles & fingernails

138
Q

therapeutic index of cytotoxic drugs

A
  • the dosage range of a particular drug in which a desired pharmacologic effect is realized without introducing toxicity to the pt
  • VERY narrow!, rescue therapy must be initiated following chemotherapy in order to restart DNA, RNA and protein synthesis*
139
Q

certain chemo drugs are known to:

A
  • be teratogenic (particularly in the 1st trimester)
  • *known to suppress testicular function, spermatogenesis
  • pregnant or breast-feeding women should be excused from preparing hazardous drugs & consider excusing men actively trying to father a child for a specified time period
140
Q

what 2 precautions must be taken:

A
  • 1) use of a vertical flow hood

2) proper handling technique

141
Q

Vertical flow hood

A
  • HEPA filter and fan plenum
  • moves air: *downward direction, away from the operator
  • purpose: protection of personnel/pharmacist, prevent release of aerosolized drug*
142
Q

Type A cabinet

A
  • 70% back into the cabinet through HEPA filter, remainder returns to room through HEPA filter
  • under positive pressure: disadvantage! (if there is a breach- there is a tendency for the contamination to come out and go into the room)
143
Q

Type B1 cabinet

A
  • 30% back into the cabinet through HEPA filter, remainder vented to the outside through HEPA filter
  • under negative pressure
144
Q

Type B2 cabinet

A
  • 100% vented to the outside

* under negative pressure

145
Q

Type B3 cabinet

A
  • 70% through HEPA filters back into the cabinet, remainder vented to the outside
  • under negative pressure
146
Q

Biological safety cabinet leave on & operating:

A

*24 hours per day & 7 days per week
Turning off blower will cause recirculation of contaminants into clean room
if really need to turn off: throughly clean before shutdown, cover operator opening with plastic and tape before shutdown

147
Q

Chemo glove rules

A
  • 2 fresh pairs at beginning of task: 1 pair under gown & 1 pair over cuffs
    change: **
    1) outer pair immediately if mildly contaminated
    2) both pairs if outer pair is torn or punctured
    3) both pairs in the event of a spill
    4) both pairs after each hour of use
148
Q

Ampules (steps)

A

-ensure tip contents transferred to main body: gentle tapping against work surface, swirling, gentle finger snap

149
Q

Type 1 glass container

A
  • borosilicate glass
  • highly resistant to H2O attack
  • high chemical stability
  • low thermal expansion coefficient –> high resistance to thermal shock
  • may be sterilized before or after filling
150
Q

Type 2 glass container

A
  • glass is treated with soda lime
  • sterilization with dry heat prior to filing is preferred
  • pH of contents must be <7 –> for entire time prior to expiration date
  • suitable for: solutions, powders and oils
151
Q

Type 3 glass container

A
  • soda lime glass
  • sterilization with dry heat prior to filing is REQUIRED
  • pH of contents must be <7 –> for entire time prior to expiration date
  • suitable for: solutions, powders, oils